Stay updated on Lintuzumab in CLAG-M for AML Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.

Latest updates to the Lintuzumab in CLAG-M for AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision indicator (v3.4.2) was added to the history, and the operating-status notice about government funding was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a government funding notice banner and updated the page footer revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedAdds Record History and Study Record Versions with navigation and export options, plus a glossary toggle, and removes No FEAR Act data from the page.SummaryDifference17%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the Study History page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision: v3.3.2 was added in the Study Record Versions section, replacing the previous v3.2.0 entry.SummaryDifference0.1%

Stay in the know with updates to Lintuzumab in CLAG-M for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.